Stem Cells Poised to Grow Organs for Transplant : Zannos Grekos, MD Presents Clinical Data of Research with Adult Stem Cells to Physicians at International Regenerative Biomedicine C...((/images_v4/bullet_solid2.gif); Grekos ...),Health

Date:12/22/2008

(/images_v4/bullet_solid2.gif);">

Grekos also highlighted several case studies to illustrate his team's success with Adult Stem Cells. According to their findings, cardiac disease patients experience an average increase of 21% in ejection rates as well as measurable improvements in congestive heart failure class status, some in as little as one month post-treatment. "We are able to bring patients from a Class IV congestive heart failure status to a Class II status in less than 180 days," said Grekos. Regenocyte Therapeutic's clinical data from PET scans confirm that Adult Stem Cells have the ability to engraft themselves into areas damaged by myocardial infarction (heart attacks) and turn into viable new heart muscle. "Three months after treatment, cardiac nuclear scans of the areas treated reveal reversal of damage. We have been able to take patients off the transplant list, and we have been doing it consistently."

Most recently, physicians at the Dominican Republic division of Regenocyte announced clinical results of a 46-year-old patient with pulmonary hypertension who was treated with Adult Stem Cells. His pulmonary artery mean pressure went from 41mmHg (severe pulmonary hypertension) to 24 mmHg (normal) in six months. The patient's saturations are now consistently high and he no longer needs to be supplemented with oxygen continuously or considered for a lung transplant. Another patient was successfully treated for cardiac sequelae of Fabry's Disease, and is also no longer considered for heart transplant.

Hector Rosario, MD, chief of Interventional Cardiology for the Dominican Republic division of Regenocyte, is thrilled with the clinical outcomes to date. "It is personally very gratifying to alter the prognosis in patients who have exhausted all other options," Rosario says. Leonel Francisco Liriano, MD, professor of medicine at Pontifical Catholic University School of Medicine and medical director of
'/>"/>

Source: PRWeb Copyright©2008 Vocus, Inc. All rights reserved

1 GOOD

Page: 1 2 3
Related medicine news :

1. Tumors use enzyme to recruit regulatory T-cells and suppress immune response
2. Brain cells work differently than previously thought
3. Embryonic Stem Cells Repair Human Heart
4. Embryonic Human Stem Cells May Help Repair Heart Muscle, Lab Study Shows
5. Circulating fats kill transplanted pancreas cells, study shows
6. Experimental anti-cancer drug made from corn lillies kills brain tumor stem cells
7. Melanoma drug revs immune cells but cancer cells ignore it
8. Scientists explain how insulin secreting cells maintain their glucose sensitivity
9. Embryonic stem cells used to grow cartilage
10. Molecular probe paints cancer cells in living animals, Stanford researchers find
11. USC researcher identifies stem cells in tendons that regenerate tissue in animal model